Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-22-000156

EVP, Quality & Ethics, and CPL acquired 96,310 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Glessner Coleen EVP, Quality & Ethics, and CPL 2022-12-09 Grant or award +24,078 35,904 D: show line 1 in the form
Glessner Coleen EVP, Quality & Ethics, and CPL 2022-12-09 Grant or award +72,232 108,136 D: show line 2 in the form
Loading xslF345X03/wf-form4_167096997706667.xml…